← Back to Clinical Trials
Recruiting NCT06819943

NCT06819943 Effectiveness of Platform-Based Lateralization Therapy in Reducing Interface Pressure Between The Patient And The Support Surface

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06819943
Status Recruiting
Phase
Sponsor University of Sao Paulo General Hospital
Condition Respiratory Insufficiency
Study Type INTERVENTIONAL
Enrollment 25 participants
Start Date 2024-06-01
Primary Completion 2026-12

Trial Parameters

Condition Respiratory Insufficiency
Sponsor University of Sao Paulo General Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 25
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-06-01
Completion 2026-12
Interventions
Automated Lateral Rotation Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Pressure injury (PI) is characterized as damage to the skin and/or underlying tissues resulting from sustained pressure or a combination of pressure and shear forces between the patient and the support surface. Prolonged pressure is a well-established risk factor in the development of PIs. Frequent repositioning and routine patient care have been recognized for decades as integral components of PI prevention and treatment protocols. The duration of interface pressure is as critical as its magnitude. When interface pressure exceeds the mean capillary blood pressure, blood flow can be compromised, leading to ischemia in affected areas, which may progress to necrosis if sustained over time. Furthermore, it is widely accepted in the literature that tissue becomes at risk when interface pressure exceeds 30 to 32 mmHg. In this context, continuous lateral rotation therapy (CLRT) offers a potential alternative for managing critically ill patients. CLRT involves continuous mechanical rotation of the patient in the lateral plane. However, its effects on skin integrity remain poorly understood. Despite the rationale behind and widespread recommendation of repositioning, the lack of robust evaluations on how repositioning impacts interface pressure creates uncertainty, underscoring the need for high-quality trials to assess different strategies for implementation. Although lateralization is a pragmatic strategy for preventing pressure injuries, its use in critically ill patients requires an integrated assessment of respiratory, hemodynamic, and gastroesophageal effects. Therefore, this study proposes an innovative approach by evaluating, for the first time, the effectiveness of automated postural change with simultaneous monitoring of tissue integrity, pulmonary function, cardiovascular stability, and gastroesophageal protection. The aim is to optimize pressure injury prevention, improve pulmonary mechanics, ensure hemodynamic stability, and preserve gastroesophageal safety in critically ill patients.

Eligibility Criteria

Inclusion Criteria * Adult and elderly patients, aged 18 years or older; * Patients under controlled or assisted mechanical ventilation, not yet eligible for weaning. Exclusion Criteria * Requirement of norepinephrine \> 0.3 mcg/kg/min or mean arterial pressure \< 60 mmHg, despite the use of vasopressor agents; * Cardiac arrhythmias or bleeding leading to hemodynamic instability; * Neurological diseases or symptoms; * Spinal cord injury, such as paraplegia; * Cardiac pacemaker dependence; * Contraindications to hypercapnia, such as intracranial hypertension or acute coronary syndrome; * Air leakage from chest drains, presence of pneumothorax or undrained subcutaneous emphysema; * Presence of pre-existing pressure injuries in bony prominences (sacral, occipital, scapular, or calcaneal) at admission; * Medical refusal to include the patient in the study.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology